Clinical characteristics and frequency of chronic complications in persons with Diabetes Mellitus type 2, in Granma province.
Keywords:
DIABETES MELLTUS, TYPE II / COMPLICATIONS, HYPERTENSION/COMPLICATIONS.Abstract
O t was carried out a descriptive transversal research with the first 300 diabetic patients, type 2, hospitalized in the Diabetics Care Center in Granma, in the period from October 2007-to May 2008, with the objective to develop a clinic characterization and know the frequency of chronic complications of diabetes mellitus. The first datum was obtained from the health histories from which there were obtained the following data: age, sex, race, address, and toxic habits, familiar antecedents of diabetes, the starting age and its manifestation, nutritional stage, hypertension and chronic complications of diabetes. It was found and increase of overweight and obese patients (72, 9%) as well as abdominal obesity (61.3%). Hypertension was presented in the 70% of the analyzed cases. The average age was of 55, 9 % years. A 48, 7% of the cases presented some kind of chronic diabetes complication. The diabetic polyneuropathy prevailed (29, 3%) followed by diabetic macroangiopathy (26,3%) and diabetic retinopathy (17.3%). Finally it can be said that the frequency of hypertension, overweight and obesity as well as the abdominal obesity in patients with diabetes mellitus type 2 in our environment is high what may be an influence in the high incidence of chronic complications in these cases.
Downloads
References
1. Colectivo de autores. EpidemiologÃa de la diabetes mellitus. En: Sierra ID, Mendivel CO, Hernández B, Pérez CU, DÃaz A, Márquez G, et al. Hacia el manejo práctico de la diabetes tipo 2. Bogotá: Novonordisk; 2005.p.1- 9.
2. Sicree R y Shaw J. Type 2 diabetes: An epidemic or not and why it is happening Diabetes & Metabolic Syndrome. Clinical Research & Reviews 1(2): 75-81, 2007.
3. Dirección Nacional de estadÃsticas. MINSAP Informe anual 2005.
4. Blonde L. Consecuencias, costos, diagnóstico. Prevención y efectividad del tratamiento de la diabetes tipo 2: Una epidemia estadounidense. Am. Diabetes 2002; 6:3-8.
5. World Health Organization (WHO). Definition and classification of diabetes mellitus and complications. Report of WHO consultation. Part 1: Diagnosis and classification of Diabetes mellitus. World Health Organization. Department of Noncommunicable Disease Surveillance. Geneva, 1999.
6. Seventh Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JMCV). Hypertension 2003; 42:1206-52.
7. Worl d Health Organization (WHO). Expert Committee Phycal Status. The use and interpretation of anthropometry. Geneva. WHO Technical Report Serie No 854; 1995.
8. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP), Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001; 285:2486-97.
9. L´Esperance FA. Diabetic retinopathy. Ophtalmic Laser Fotocoagulation, photoradiation and sugery. Diabetic Retinopathy In: L' Esperance FA (Jr). St Louis-Toronto-Londres. Ed.Mosby 1983:275-85.
10. Dyck PJ, Karness JL, Daube JR,Obrien PH, Service FJ. Clinical and neuropathologic criteria for the diagnosis and staging of diabetic polineuropathy. Brain 1985; 108: 861¬ a. 80.
11. Escobar F. Pie diabético y factores de riesgo. Av Diabetol 1995; 5:71-76.
12. Ito H, Harano Y, Suzuky M, Hattori y, Takeuchi M, Inada H, et al. Risk factor analyses for macrovascular complication in nonobese NIDDM patients’ multiclinal study for diabetic macroangiopathy. Diabetes 1996; 45 (Suppl 3):519-23
13. Bray GA. Medical consequences of obesity. J Clin Endocrinol Metab. 2004; 89:2583-9.
14. Scheen AJ. From obesity to diabetes: why, when and who? Acta Clin Belg. 2000; 55:9-15.
15. Oscar DÃaz DÃaz, José Luis Valenciaga RodrÃguez y Dra. Enma DomÃnguez Alonso. CaracterÃsticas clÃnicas de la diabetes mellitus tipo 2 en el municipio de Güines. Año 2002. Rev Cubana Endocrinol v.14 n.1 Ciudad de la Habana ene.-abr. 2003.
16. Despres JP. Is visceral obesity the cause of the metabolic syndrome? Ann Med. 2006; 38:52-63.
17. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, et al. INTERHEART Study Investigators. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet. 2005; 366: 1640-9.
18. HDS HiDSG. Hypertension in Diabetes Study (HDS), 1: prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications. J Hypertens. 1993; 11:309–317.
19. Dr. Manuel E. Licea Puig, Dr. Omar Singh Linares, Dr. Alain Smith Limonta y Dr. Rolando MartÃnez GarcÃa. Frecuencia, caracterÃsticas clÃnicas y resultados terapéuticos de la hipertensión arterial en diabéticos tipo 2 de un área de salud. Rev Cubana Endocrinol v.13 n.2 Ciudad de la Habana Mayo-ago. 2002
20. OMS. BoletÃn de Investigaciones sobre Servicios de Salud. Genéve: OMS; 1990:16-9.
21. Grepan. FS. Hormonas pancreáticas y Diabetes Mellitas. En Endocrinologia basica y clinica,pp 187-260, Ed El Manual Moderno, SA. De CV. Mexico, DF, 1995.
22. Romero Mestre JC, Licea Puig ME. Patogénesis de la polineuropatÃa diabética Rev Cubana Endocrinol 1996; 1:44-51.
23. Brown MJ, Bird SJ, Watling S, Kaleta H, Hayes L, Eckert S, et al. Zenarest study. Natural progression of diabetic peripheral neuropathy in the Zenarestat study population. Diabetes Care. 2004; 27:1153-9.
24. Kowluru RA. Effect of advanced glycation end products on accelerated opoptosis of retinal capillary cells under in vitro conditions. Life Sci. 2005; 76:1051-60.
25. Frank RN. Diabetic Retinopathy. N Engl J Med. 2004; 350:48-58.
26. Varghese A, Deepa R, Rema M, Mohan V. Prevalence of microalbuminuria in type 2 diabetes mellitus at diabetes centre in Southern India. Postgrad Med 2001; 77:399-402.
27. Licea ME, Ezcurra E, Arranz MC, Moreno D, Barroso O. Excreción de albúmina urinaria en el diabético: Su relación con las complicaciones vasculares. Rev Cubana Méd 1991; 2: 44-53.
28. Bloomgarden ZT. Third Annual World Congress on the Insulin Resistance SÃndrome: Atherothrombotic disease. Diabetes Care. 2006; 29(7):1700-6.
29. Grupo de trabajo Diabetes mellitus y Enfermedad cardiovascular de la Sociedad Española de Diabetes. Diabetes mellitus y riesgo cardiovascular. Recomendaciones del Grupo de trabajo Diabetes mellitus y Enfermedad cardiovascular de la Sociedad Española de Diabetes. Clin Invest Arterioscl 2004; 16(2):74-8.
Downloads
Published
How to Cite
Issue
Section
License
Avisos de derechos de autor propuestos por Creative Commons
1. Política propuesta para revistas que ofrecen acceso abierto
Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:- Los autores/as conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación esta revista.
- Los autores/as podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada (p. ej.: depositarla en un archivo telemático institucional o publicarla en un volumen monográfico) siempre que se indique la publicación inicial en esta revista.
- Se permite y recomienda a los autores/as difundir su obra a través de Internet (p. ej.: en archivos telemáticos institucionales o en su página web) antes y durante el proceso de envío, lo cual puede producir intercambios interesantes y aumentar las citas de la obra publicada. (Véase El efecto del acceso abierto).
